Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2209079 | 0.74 | SMN1; SMN2 (0.34) | SMN1; SMN2 | |
| SCHEMBL17113508 | 0.72 | NEK2 (0.35) | — | |
| SCHEMBL20390537 | 0.68 | SMN1; SMN2 (0.38) | SMN1; SMN2 | |
| SCHEMBL11188596 | 0.67 | TSHR (0.35) | SMN1; SMN2 | |
| SCHEMBL243842 | 0.66 | — | — | |
| SCHEMBL561840 | 0.66 | POLB (0.32) | — | |
| SCHEMBL8363742 | 0.64 | SMN1; SMN2 (0.31) | SMN1; SMN2 | |
| SCHEMBL21189243 | 0.63 | ALDH1A1 (0.36) | SMN1; SMN2 | |
| SCHEMBL5647311 | 0.63 | SMN1; SMN2 (0.32) | SMN1; SMN2 | |
| SCHEMBL6556055 | 0.63 | SMN1; SMN2 (0.32) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090274947-A1 | Imidazolidinone nitroxides as electrode materials for energy storage devices | CIBA CORP. | 2009-11-05 | — | — | US | disclosed |
| EP-2062311-A2 | IMIDAZOLIDINONE NITROXIDES AS ELECTRODE MATERIALS FOR ENERGY STORAGE DEVICES | Ciba Holding Inc. (CH) | 2009-05-27 | — | — | EP | disclosed |
| WO-2008031733-A2 | IMIDAZOLIDINONE NITROXIDES AS ELECTRODE MATERIALS FOR ENERGY STORAGE DEVICES | CIBA HOLDING INC. (CH) | 2008-03-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090274947-A1 | Imidazolidinone nitroxides as electrode materials for energy storage devices | IDH2, NQO1, NOX1 | SMN1; SMN2 1835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.